Cargando…

Validation of a newly proposed histopathological classification in Japanese patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis

BACKGROUND: A new histopathological classification of anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis was recently proposed. We evaluated the predictive value of this classification for renal outcome in Japanese patients. METHODS: We enrolled 122 patients with ANCA-associat...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwakiri, Takashi, Fujimoto, Shouichi, Kitagawa, Kiyoki, Furuichi, Kengo, Yamahana, Junya, Matsuura, Yunosuke, Yamashita, Atsushi, Uezono, Shigehiro, Shimao, Yoshiya, Hisanaga, Shuichi, Tokura, Takeshi, Wada, Takashi, Kitamura, Kazuo, Asada, Yujiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3704260/
https://www.ncbi.nlm.nih.gov/pubmed/23773275
http://dx.doi.org/10.1186/1471-2369-14-125
_version_ 1782275973811535872
author Iwakiri, Takashi
Fujimoto, Shouichi
Kitagawa, Kiyoki
Furuichi, Kengo
Yamahana, Junya
Matsuura, Yunosuke
Yamashita, Atsushi
Uezono, Shigehiro
Shimao, Yoshiya
Hisanaga, Shuichi
Tokura, Takeshi
Wada, Takashi
Kitamura, Kazuo
Asada, Yujiro
author_facet Iwakiri, Takashi
Fujimoto, Shouichi
Kitagawa, Kiyoki
Furuichi, Kengo
Yamahana, Junya
Matsuura, Yunosuke
Yamashita, Atsushi
Uezono, Shigehiro
Shimao, Yoshiya
Hisanaga, Shuichi
Tokura, Takeshi
Wada, Takashi
Kitamura, Kazuo
Asada, Yujiro
author_sort Iwakiri, Takashi
collection PubMed
description BACKGROUND: A new histopathological classification of anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis was recently proposed. We evaluated the predictive value of this classification for renal outcome in Japanese patients. METHODS: We enrolled 122 patients with ANCA-associated glomerulonephritis diagnosed at several institutions in Japan between January 2000 and March 2010. Twenty patients were excluded because of observation durations of <1 year, and/or because their biopsy specimens contained <10 glomeruli. Renal biopsy specimens were categorized into four classes according to the proposed classification. We evaluated the predictive value of immunohistochemical staining for α-smooth muscle actin (SMA), Wilm’s tumor 1 (WT1), CD68, and cytokeratin for end-stage renal disease (ESRD). RESULTS: The study population included 54 men and 48 women. Age, estimated glomerular filtration rate (eGFR), and proteinuria were 66.3 ± 11.3 years, 21.6 ml/min. and 1.10 g/24 h, respectively. Eighty-six patients were positive for myeloperoxidase-ANCA, five were positive for proteinase 3-ANCA, and 11 were negative for both antibodies. Median follow-up time was 41.0 months. Twenty-three patients (22.5%) developed ESRD during the follow-up period. Twelve patients died during follow up; 7/12 patients developed ESRD before death, and 5/12 patients died without ESRD. The incidence of ESRD increased with sequential categories: focal, 2/46 (4.3%); crescentic, 9/32 (28%); mixed, 8/18 (44%); and sclerotic, 4/6 (67%). The focal class had the best renal survival and the sclerotic class had the worst renal survival (p < 0.001). Kaplan-Meier renal survival analysis was similar to that of the new classification system proposal. In the multivariate analysis, the classification system tended to be a prognostic factor for ESRD (p = 0.0686, crescentic, mixed and sclerotic vs. focal, hazard ratio (HR) [95% confidence interval, CI]; 2.99 [0.61–22.7], 5.04 [1.11–36.4] and 9.93 [1.53–85.7], respectively). α-SMA-positivity also tended to be associated with ESRD (p = 0.1074). CONCLUSION: The new histopathological classification was associated with eGFR at 1 year and tended to be associated with ESRD in our Japanese cohort with ANCA-associated glomerulonephritis. α-SMA positivity might be an additional prognostic factor for ESRD.
format Online
Article
Text
id pubmed-3704260
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-37042602013-07-09 Validation of a newly proposed histopathological classification in Japanese patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis Iwakiri, Takashi Fujimoto, Shouichi Kitagawa, Kiyoki Furuichi, Kengo Yamahana, Junya Matsuura, Yunosuke Yamashita, Atsushi Uezono, Shigehiro Shimao, Yoshiya Hisanaga, Shuichi Tokura, Takeshi Wada, Takashi Kitamura, Kazuo Asada, Yujiro BMC Nephrol Research Article BACKGROUND: A new histopathological classification of anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis was recently proposed. We evaluated the predictive value of this classification for renal outcome in Japanese patients. METHODS: We enrolled 122 patients with ANCA-associated glomerulonephritis diagnosed at several institutions in Japan between January 2000 and March 2010. Twenty patients were excluded because of observation durations of <1 year, and/or because their biopsy specimens contained <10 glomeruli. Renal biopsy specimens were categorized into four classes according to the proposed classification. We evaluated the predictive value of immunohistochemical staining for α-smooth muscle actin (SMA), Wilm’s tumor 1 (WT1), CD68, and cytokeratin for end-stage renal disease (ESRD). RESULTS: The study population included 54 men and 48 women. Age, estimated glomerular filtration rate (eGFR), and proteinuria were 66.3 ± 11.3 years, 21.6 ml/min. and 1.10 g/24 h, respectively. Eighty-six patients were positive for myeloperoxidase-ANCA, five were positive for proteinase 3-ANCA, and 11 were negative for both antibodies. Median follow-up time was 41.0 months. Twenty-three patients (22.5%) developed ESRD during the follow-up period. Twelve patients died during follow up; 7/12 patients developed ESRD before death, and 5/12 patients died without ESRD. The incidence of ESRD increased with sequential categories: focal, 2/46 (4.3%); crescentic, 9/32 (28%); mixed, 8/18 (44%); and sclerotic, 4/6 (67%). The focal class had the best renal survival and the sclerotic class had the worst renal survival (p < 0.001). Kaplan-Meier renal survival analysis was similar to that of the new classification system proposal. In the multivariate analysis, the classification system tended to be a prognostic factor for ESRD (p = 0.0686, crescentic, mixed and sclerotic vs. focal, hazard ratio (HR) [95% confidence interval, CI]; 2.99 [0.61–22.7], 5.04 [1.11–36.4] and 9.93 [1.53–85.7], respectively). α-SMA-positivity also tended to be associated with ESRD (p = 0.1074). CONCLUSION: The new histopathological classification was associated with eGFR at 1 year and tended to be associated with ESRD in our Japanese cohort with ANCA-associated glomerulonephritis. α-SMA positivity might be an additional prognostic factor for ESRD. BioMed Central 2013-06-17 /pmc/articles/PMC3704260/ /pubmed/23773275 http://dx.doi.org/10.1186/1471-2369-14-125 Text en Copyright © 2013 Iwakiri et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Iwakiri, Takashi
Fujimoto, Shouichi
Kitagawa, Kiyoki
Furuichi, Kengo
Yamahana, Junya
Matsuura, Yunosuke
Yamashita, Atsushi
Uezono, Shigehiro
Shimao, Yoshiya
Hisanaga, Shuichi
Tokura, Takeshi
Wada, Takashi
Kitamura, Kazuo
Asada, Yujiro
Validation of a newly proposed histopathological classification in Japanese patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis
title Validation of a newly proposed histopathological classification in Japanese patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis
title_full Validation of a newly proposed histopathological classification in Japanese patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis
title_fullStr Validation of a newly proposed histopathological classification in Japanese patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis
title_full_unstemmed Validation of a newly proposed histopathological classification in Japanese patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis
title_short Validation of a newly proposed histopathological classification in Japanese patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis
title_sort validation of a newly proposed histopathological classification in japanese patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3704260/
https://www.ncbi.nlm.nih.gov/pubmed/23773275
http://dx.doi.org/10.1186/1471-2369-14-125
work_keys_str_mv AT iwakiritakashi validationofanewlyproposedhistopathologicalclassificationinjapanesepatientswithantineutrophilcytoplasmicantibodyassociatedglomerulonephritis
AT fujimotoshouichi validationofanewlyproposedhistopathologicalclassificationinjapanesepatientswithantineutrophilcytoplasmicantibodyassociatedglomerulonephritis
AT kitagawakiyoki validationofanewlyproposedhistopathologicalclassificationinjapanesepatientswithantineutrophilcytoplasmicantibodyassociatedglomerulonephritis
AT furuichikengo validationofanewlyproposedhistopathologicalclassificationinjapanesepatientswithantineutrophilcytoplasmicantibodyassociatedglomerulonephritis
AT yamahanajunya validationofanewlyproposedhistopathologicalclassificationinjapanesepatientswithantineutrophilcytoplasmicantibodyassociatedglomerulonephritis
AT matsuurayunosuke validationofanewlyproposedhistopathologicalclassificationinjapanesepatientswithantineutrophilcytoplasmicantibodyassociatedglomerulonephritis
AT yamashitaatsushi validationofanewlyproposedhistopathologicalclassificationinjapanesepatientswithantineutrophilcytoplasmicantibodyassociatedglomerulonephritis
AT uezonoshigehiro validationofanewlyproposedhistopathologicalclassificationinjapanesepatientswithantineutrophilcytoplasmicantibodyassociatedglomerulonephritis
AT shimaoyoshiya validationofanewlyproposedhistopathologicalclassificationinjapanesepatientswithantineutrophilcytoplasmicantibodyassociatedglomerulonephritis
AT hisanagashuichi validationofanewlyproposedhistopathologicalclassificationinjapanesepatientswithantineutrophilcytoplasmicantibodyassociatedglomerulonephritis
AT tokuratakeshi validationofanewlyproposedhistopathologicalclassificationinjapanesepatientswithantineutrophilcytoplasmicantibodyassociatedglomerulonephritis
AT wadatakashi validationofanewlyproposedhistopathologicalclassificationinjapanesepatientswithantineutrophilcytoplasmicantibodyassociatedglomerulonephritis
AT kitamurakazuo validationofanewlyproposedhistopathologicalclassificationinjapanesepatientswithantineutrophilcytoplasmicantibodyassociatedglomerulonephritis
AT asadayujiro validationofanewlyproposedhistopathologicalclassificationinjapanesepatientswithantineutrophilcytoplasmicantibodyassociatedglomerulonephritis